High Hampton Holdings (CSE:HC,OTC:HHPHF,FSE:OHCN) CEO Gary Latham joined the Midas Letter to discuss the company’s recent shift in business strategy and its investment in the 2083 Group Inc. High Hampton will be focusing on developing cannabis products and brands due to their higher margins.

High Hampton has a 15,000-square-foot facility in Cudahy, California. It has six licenses for the facility, which will allow High Hampton to distribute medical and recreational cannabis throughout the state. According to Latham, the facility will provide a foundation for the company. It will house the company’s nursery, distribution, non-storefront retail, edibles kitchen and manufacturing capabilities once the facility is fully operational. High Hampton’s delivery license will play an essential role in future business operations as it allows the company to enter counties and municipalities that have otherwise restricted retail cannabis operations.


Latham also talked about the company’s CaliGold and Mojave Jane brands. High Hampton is already shipping products and recently released new products for their CaliGold edibles brand. Latham pointed out that the CaliGold brand has done well in California’s market.

High Hampton has also gained a minority interest in the 2083 Group. The 2083 Group developed the Speedweed delivery platform, an on-demand cannabis delivery service with a consumer database of over 250,000 consumers throughout California. Speedweed currently works with 10 dispensaries in the state and is growing rapidly. There are approximately 800 dispensaries throughout California, and they only cover a small area. Latham stated that High Hampton is aiming to service those who do not have a dispensary near them. The investment also offers High Hampton the opportunity to access market data, understand consumer demands and to develop products and brands that meet those demands.

To watch the full interview, click here.

Click here to connect with High Hampton Holdings Corp (CSE:HC, OTC:HHPHF, FSE:OHCN) for an Investor Presentation. 

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less